Hall Pass



5:45 – 7:00 pm Exhibit Hall Open

4:00 – 5:45 pm Plenary Keynote Presentation
4:05 – 4:20 pm Innovative Practices Awards
5:45 – 7:00 pm Welcome Reception in the Exhibit Hall with Poster Viewing


9:30 am – 6:00 pm Exhibit Hall Open

8:00 – 9:30 am Plenary Keynote Presentation
9:30 – 10:15 am Coffee & Networking in the Exhibit Hall with Poster Viewing
9:40 10:00 am Solutions Theater Presentation by Ardigen
1:50 – 2:35 pm Refreshments & Networking in the Exhibit Hall with Poster Viewing
2:00 2:20pm Solutions Theater Presentation by Thrive Bioscience
2:30 pm Raffle Drawing: Apple AirPods Pro
4:40 – 6:00 pm Best of Show Awards Reception in the Exhibit Hall with Poster Viewing
4:45 5:05 pm Solutions Theater Presentation by Ontoforce


9:30 am – 2:35 pm Exhibit Hall Open

8:00 – 9:30 am Plenary Keynote Presentation
9:30 – 10:15 am Coffee Break in the Exhibit Hall with Poster Viewing
10:00 am Raffle Drawing: Apple Watch
1:50 – 2:35 pm Refreshment Break in the Exhibit Hall with Poster Viewing
2:20 pm Raffle Drawing: Bose Wireless Headphones

**Exhibit Hours Subject to Change**

Free Exhibit Hall & Keynote Pass

In-Person Only

TUESDAY, MAY 16 | 4:00 – 5:45 pm

Innovative Practices Awards

Joseph CerroJoseph Cerro, Independent Consultant

Chris DwanChris Dwan, Independent Consultant, Dwan, LLC

Allison ProffittAllison Proffitt, Editorial Director, Bio-IT World

Plenary Keynote Introduction

David Gosalvez, PhD, Executive Director, Strategy & Informatics Portfolio, PerkinElmer Informatics

The Promise of Data, Analytics, and Technology: Fueling Scientific and Medical Breakthroughs

Anastasia ChristiansonAnastasia Christianson, PhD, Vice President, Global Head of AI, ML, Analytics, and Data, Pfizer Inc.

Edward CoxEdward Cox, Head & General Manager of Digital Health & Medicines (DHM), Pfizer

WEDNESDAY, MAY 17 | 8:00 – 9:30 am

Plenary Keynote Introduction:
Life Science Automation Opportunities – So Many Options, So Little Time

Santanu Sen Santanu Sen, Vice President, Healthcare & Life Sciences, Virtusa

The Covid pandemic has demonstrated that therapies and vaccines can be developed in 18 months with a high degree of safety and efficacy. Pioneering work done by companies involved has shed light to archaic processes that have been in existence for decades with little need for change. In this presentation, we will discuss collaborative efforts, enabling technologies, regulation, and workflow to automate these processes to advance personalized medicine initiatives.

Federated Futures: How the Largest Federated Learning Effort in Medicine Will Inform Our Next Steps

Spyridon Bakas, PhDSpyridon Bakas, PhD, Assistant Professor, Radiology & Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania

Raymond Y. Huang, MD, PhDRaymond Y. Huang, MD, PhD, Division Chief, Neuroradiology, Brigham and Women’s Hospital; Associate Professor of Radiology, Harvard Medical School

Jason Martin, Principal Engineer AI Research Science, Security Solutions Lab, Intel Labs

Is a federated learning model sufficient to handle data from 71 institutions and more than 6,000 patients located on six continents? Researchers from Penn Medicine and Intel Labs say yes. An interdisciplinary team created the largest to-date global federated learning effort to develop an accurate and generalizable machine learning model for detecting glioblastoma borders. We will share what we learned about creating and maintaining such a federation, how the software infrastructure evolved over the course of the study, and how this work will empower the future of high-quality, precision clinical care worldwide.

THURSDAY, MAY 18 | 8:00 – 9:30 am

Assessing Innovation: How Pharma Makes Tech Investment Decisions

Panel Moderator:

Aaron Mann, Chief Executive Officer, Clinical Research Data Sharing Alliance

This panel session will assemble senior leaders who evaluate new technology adoption. We will hold an interactive discussion to help provide transparency in the evaluation and decision-making process for assessing and investing in new technologies. Themes we will cover include: 1) process for evaluating, piloting, and scaling new technologies and technology approaches; 2) how an organization evaluates an emerging technology vendor landscape; 3) when and how a formal buying process becomes required, and 4) identifying key stakeholders, decision-makers, and gatekeepers.


April BinghamApril Bingham, Executive Director, Global Medical Compliance and Governance Chapter, Roche

Peter MesenbrinkPeter Mesenbrink, PhD, Executive Director, Biostatistics, Novartis Pharmaceuticals

Maria PalombiniMaria Palombini, Global Practice Leader, Healthcare & Life Sciences, IEEE Standards Association

Laszlo Vasko, Senior Director, Clinical Innovation R&D IT, Janssen Pharmaceuticals, Inc.

Submit Your Speaker Proposal

Data Platforms and Storage Infrastructure